Difference between revisions of "Senile dementia"

From Aging Chart
Jump to: navigation, search
(Autoloading by CXLParser)
(Autoloading by CXLParser)
Line 260: Line 260:
 
(.//.)<html><!--Pop-up for: Senile plaques !Pop-up-->
 
(.//.)<html><!--Pop-up for: Senile plaques !Pop-up-->
 
<div class="1J13DNQZ3-WQRX7P-2Y3" style="display:none;">
 
<div class="1J13DNQZ3-WQRX7P-2Y3" style="display:none;">
 +
  
  
Line 269: Line 270:
 
</div>(...)<!--Pop-up for: Infections  !Pop-up-->
 
</div>(...)<!--Pop-up for: Infections  !Pop-up-->
 
<div class="1J139D7TL-27QTCB7-QH" style="display:none;">
 
<div class="1J139D7TL-27QTCB7-QH" style="display:none;">
 +
  
  
Line 278: Line 280:
 
</div>(...)<!--Pop-up for: Trophic disturbances !Pop-up-->
 
</div>(...)<!--Pop-up for: Trophic disturbances !Pop-up-->
 
<div class="1J13CXN2F-1WG94Q6-1Y3" style="display:none;">
 
<div class="1J13CXN2F-1WG94Q6-1Y3" style="display:none;">
 +
  
  
Line 287: Line 290:
 
</div>(...)<!--Pop-up for: Lipofuscin !Pop-up-->
 
</div>(...)<!--Pop-up for: Lipofuscin !Pop-up-->
 
<div class="1J139BS6X-22MJ3GP-P7" style="display:none;">
 
<div class="1J139BS6X-22MJ3GP-P7" style="display:none;">
 +
  
  
Line 296: Line 300:
 
</div>(...)<!--Pop-up for: Proteins glycation !Pop-up-->
 
</div>(...)<!--Pop-up for: Proteins glycation !Pop-up-->
 
<div class="1J139KLKM-1LCXD42-V0" style="display:none;">
 
<div class="1J139KLKM-1LCXD42-V0" style="display:none;">
 +
  
  
Line 305: Line 310:
 
</div>(...)<!--Pop-up for: Inflammation !Pop-up-->
 
</div>(...)<!--Pop-up for: Inflammation !Pop-up-->
 
<div class="1J139B985-1ZQTZHN-NJ" style="display:none;">
 
<div class="1J139B985-1ZQTZHN-NJ" style="display:none;">
 +
  
  
Line 314: Line 320:
 
</div>(...)<!--Pop-up for: Synapses degeneration !Pop-up-->
 
</div>(...)<!--Pop-up for: Synapses degeneration !Pop-up-->
 
<div class="1J1396FH6-21PP2DZ-JL" style="display:none;">
 
<div class="1J1396FH6-21PP2DZ-JL" style="display:none;">
 +
  
  
Line 323: Line 330:
 
</div>(...)<!--Pop-up for: Separate neuron groups  (dopaminergic, cholinergic) !Pop-up-->
 
</div>(...)<!--Pop-up for: Separate neuron groups  (dopaminergic, cholinergic) !Pop-up-->
 
<div class="1N9KPYC9B-4K0LLK-1Q6P" style="display:none;">
 
<div class="1N9KPYC9B-4K0LLK-1Q6P" style="display:none;">
 +
  
  
Line 332: Line 340:
 
</div>(...)<!--Pop-up for: Oxidative stress !Pop-up-->
 
</div>(...)<!--Pop-up for: Oxidative stress !Pop-up-->
 
<div class="1J139HFXV-1YVJ5KD-S8" style="display:none;">
 
<div class="1J139HFXV-1YVJ5KD-S8" style="display:none;">
 +
  
  
Line 341: Line 350:
 
</div>(...)<!--Pop-up for: Phenolic  Amines (NTox) !Pop-up-->
 
</div>(...)<!--Pop-up for: Phenolic  Amines (NTox) !Pop-up-->
 
<div class="1J13F7FY6-1B2SLXD-3JR" style="display:none;">
 
<div class="1J13F7FY6-1B2SLXD-3JR" style="display:none;">
 +
  
  
Line 350: Line 360:
 
</div>(...)<!--Pop-up for: Copper ions !Pop-up-->
 
</div>(...)<!--Pop-up for: Copper ions !Pop-up-->
 
<div class="1J13D7HX2-23RYYYV-2BF" style="display:none;">
 
<div class="1J13D7HX2-23RYYYV-2BF" style="display:none;">
 +
  
  
Line 359: Line 370:
 
</div>(...)<!--Pop-up for: Mitochondrial  Dysfunction !Pop-up-->
 
</div>(...)<!--Pop-up for: Mitochondrial  Dysfunction !Pop-up-->
 
<div class="1J139F328-1LRS67J-R7" style="display:none;">
 
<div class="1J139F328-1LRS67J-R7" style="display:none;">
 +
  
  
Line 368: Line 380:
 
</div>(...)<!--Pop-up for: Platelet  Activating factor !Pop-up-->
 
</div>(...)<!--Pop-up for: Platelet  Activating factor !Pop-up-->
 
<div class="1J13FK5JT-1GBXCWM-442" style="display:none;">
 
<div class="1J13FK5JT-1GBXCWM-442" style="display:none;">
 +
  
  
Line 377: Line 390:
 
</div>(...)<!--Pop-up for: Senile dementia !Pop-up-->
 
</div>(...)<!--Pop-up for: Senile dementia !Pop-up-->
 
<div class="1J13BFW49-9W6HPG-143" style="display:none;">
 
<div class="1J13BFW49-9W6HPG-143" style="display:none;">
 +
  
  
Line 386: Line 400:
 
</div>(...)<!--Pop-up for: Myelin damage !Pop-up-->
 
</div>(...)<!--Pop-up for: Myelin damage !Pop-up-->
 
<div class="1J13CSKJN-DSN3J7-1SN" style="display:none;">
 
<div class="1J13CSKJN-DSN3J7-1SN" style="display:none;">
 +
  
  
Line 395: Line 410:
 
</div>(...)<!--Pop-up for: Quinolinic  Acid !Pop-up-->
 
</div>(...)<!--Pop-up for: Quinolinic  Acid !Pop-up-->
 
<div class="1J13DFJT7-2B8CJ4G-2LL" style="display:none;">
 
<div class="1J13DFJT7-2B8CJ4G-2LL" style="display:none;">
 +
  
  
Line 404: Line 420:
 
</div>(...)<!--Pop-up for: Microglia changes !Pop-up-->
 
</div>(...)<!--Pop-up for: Microglia changes !Pop-up-->
 
<div class="1J13D1S6Q-1MGM8YQ-219" style="display:none;">
 
<div class="1J13D1S6Q-1MGM8YQ-219" style="display:none;">
 +
  
  
Line 413: Line 430:
 
</div>(...)<!--Pop-up for: Cerebral atherosclerosis !Pop-up-->
 
</div>(...)<!--Pop-up for: Cerebral atherosclerosis !Pop-up-->
 
<div class="1J13BLR95-19DY8FH-19Q" style="display:none;">
 
<div class="1J13BLR95-19DY8FH-19Q" style="display:none;">
 +
  
  
Line 422: Line 440:
 
</div>(...)<!--Pop-up for: Disturbances in neocortex, hippocampus, hypothalamus, substantia nigra !Pop-up-->
 
</div>(...)<!--Pop-up for: Disturbances in neocortex, hippocampus, hypothalamus, substantia nigra !Pop-up-->
 
<div class="1J13FWZB8-1GJ6DPR-4KL" style="display:none;">
 
<div class="1J13FWZB8-1GJ6DPR-4KL" style="display:none;">
 +
  
  
Line 431: Line 450:
 
</div>(...)<!--Pop-up for: Injuries  !Pop-up-->
 
</div>(...)<!--Pop-up for: Injuries  !Pop-up-->
 
<div class="1J1399ZLS-1KCBBCJ-N2" style="display:none;">
 
<div class="1J1399ZLS-1KCBBCJ-N2" style="display:none;">
 +
  
  
Line 440: Line 460:
 
</div>(...)<!--Pop-up for: Hypertension  !Pop-up-->
 
</div>(...)<!--Pop-up for: Hypertension  !Pop-up-->
 
<div class="1J13CRWTB-B7X8M9-1RP" style="display:none;">
 
<div class="1J13CRWTB-B7X8M9-1RP" style="display:none;">
 +
  
  
Line 449: Line 470:
 
</div>(...)<!--Pop-up for: Dopamine  Oxidation !Pop-up-->
 
</div>(...)<!--Pop-up for: Dopamine  Oxidation !Pop-up-->
 
<div class="1J139QCJ3-QG8QGF-VZ" style="display:none;">
 
<div class="1J139QCJ3-QG8QGF-VZ" style="display:none;">
 +
  
  
Line 458: Line 480:
 
</div>(...)<!--Pop-up for: Ischemia  !Pop-up-->
 
</div>(...)<!--Pop-up for: Ischemia  !Pop-up-->
 
<div class="1J1399SKF-2421FX1-MQ" style="display:none;">
 
<div class="1J1399SKF-2421FX1-MQ" style="display:none;">
 +
  
  
Line 467: Line 490:
 
</div>(...)<!--Pop-up for: Glutamate !Pop-up-->
 
</div>(...)<!--Pop-up for: Glutamate !Pop-up-->
 
<div class="1J13D83HL-19F51S7-2CD" style="display:none;">
 
<div class="1J13D83HL-19F51S7-2CD" style="display:none;">
 +
  
  
Line 476: Line 500:
 
</div>(...)<!--Pop-up for: Amyloid  !Pop-up-->
 
</div>(...)<!--Pop-up for: Amyloid  !Pop-up-->
 
<div class="1J139BZGQ-2CD52M2-PQ" style="display:none;">
 
<div class="1J139BZGQ-2CD52M2-PQ" style="display:none;">
 +
  
  
Line 485: Line 510:
 
</div>(...)<!--Pop-up for: Neurotoxic effects !Pop-up-->
 
</div>(...)<!--Pop-up for: Neurotoxic effects !Pop-up-->
 
<div class="1J13D6FDC-1KHG0XN-28Q" style="display:none;">
 
<div class="1J13D6FDC-1KHG0XN-28Q" style="display:none;">
 +
  
  
Line 494: Line 520:
 
</div>(...)<!--Pop-up for: Axons damage !Pop-up-->
 
</div>(...)<!--Pop-up for: Axons damage !Pop-up-->
 
<div class="1N9KNVRDW-5GSLT2-1PW5" style="display:none;">
 
<div class="1N9KNVRDW-5GSLT2-1PW5" style="display:none;">
 +
  
  

Revision as of 13:35, 13 May 2015

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.